Search in the Abstract Database

Search Abstracts 2011

* = Presenting author

P193. Can duration and severity of chronic bowel disease influence patients' psychosocial functioning?

G. Hauser1, M. Tkalcic2, S. Pletikosic2, B. Mijandrusic-Sincic1, D. Stimac1

1University Hospital Rijeka, Rijeka, Croatia; 2Faculty of Humanities and Social Sciences, Rijeka, Croatia

Aim: Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) are chronic bowel disorders which are characterized with unpredictable course and frequent remissions and exacerbations. We assumed that severity and duration of chronic illness and uncertainty which follows such disorder could be related to the level of anxiety and depression and reduced health-related quality of life. The aim of this study was to investigate relation between the diseases' duration and severity and psychosocial variables.

Materials and Methods: At the setting of the University Gastroenterology Clinic we enrolled 150 IBD (80 UC and 70 CD) patients (83 males-55.33%; mean age 43.55 years, SD = 13.78) and 95 IBS patients (32 males – 33.68%; mean age 47.33 years, SD = 13.35). All patients fulfilled Spielberger's Trait Anxiety Index (STAI), Beck Depression Inventory (BDI), Short Form SF-36, Inflammatory Bowel Disease Questionnaire and Irritable Bowel Syndrome Questionnaire. CDAI, CAI UC and FBDSI were used to assess severity of diseases.

Results: No correlations between duration of IBD and psychosocial variables (STAI r = −0.03; BDI r = −0.09; IBDQ r = −0.05; SF-36 physical r = 0.08 and SF-36 mental r = 0.1) were found. Also duration of IBS do not correlate with psychosocial variables (STAI r = −0.04; BDI r = −0.02; IBS 36 r = −0.04; SF-36 physical r = 0.07 and SF-36 mental r = 0.06). Considering severity of IBS we found significant negative correlation between FBDSI/physical component SF 36 (r = −0.32) and FBDSI/IBS-36 (r = 0.41). CAI UC significantly correlated with BDI (r = 0.31) and IBDQ (r = 0.34) while CDAI negatively correlates with SF-36 mental component.

Conclusions: Disease duration does not increase depression and anxiety in IBD and IBS patients nor does it reduce significantly general and specific QoL. On the other hand, disease severity affects all the above-mentioned variables. Therefore, we may conclude that by controlling disease activity we can improve HRQoL and reduce anxiety and depression in patients/with chronic bowel diseases/although they suffer from a long-lasting chronic bowel disease.